semaglutide+bpc-157 Semaglutide + BPC-157 (2mL) Compounded glucagon-like peptide-1 receptor agonists
Description
Nat Med (2019) 25:182232
The Sikiric research group has noted across multiple publications the absence of a documented LD50 across oral BPC-157 administration studies in rodent models a finding attributed to the peptides endogenous origin from a protective gastric juice protein rather than a designed synthetic xenobiotic
While much of the conversation around peptides comes from social media and fitness communities, there is also ongoing scientific work including here in Canada exploring their potential role in medicine
The key difference lies in how the body processes them
